A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...

Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically ...

Download our mobile apps to personalize your Sportsnet experience, get breaking news alerts and watch Sportsnet+ on the go.

Braves calling up Craig Kimbrel from Triple-A after bullpen's 7-run meltdown in 9th inning vs. D-backs The Braves lost to the D-Backs on Thursday after giving up seven runs in the ninth inning.